Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma

Blood Cancer Journal

Volumn 3, Issue 4, 2013, Pages

  Porrata, L F ^a   Ristow, K M ^a   Habermann, T M ^a   Macon, W R ^b   Witzig, T E ^a   Colgan, J P ^a   Inwards, D J ^a   Ansell, S M ^a   Micallef, I N ^a   Johnston, P B ^a   Nowakowski, G ^a   Thompson, C A ^a   Markovic, S N ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

ABVD chemotherapy; Classical Hodgkin lymphoma; Survival ALC AMC ratio

Indexed keywords

ALBUMIN; BLEOMYCIN; DACARBAZINE; DOXORUBICIN; HEMOGLOBIN; VINBLASTINE;

ABSOLUTE LYMPHOCYTE MONOCYTE RATIO; ADULT; AGED; ARTICLE; BLOOD; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLASSICAL HODGKIN LYMPHOMA; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOLOGICAL PARAMETERS; LEUKOCYTE COUNT; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; TUMOR MICROENVIRONMENT;

EID: 84878321704     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2013.8     Document Type: Article

References (16)

1. Porrata LF, Ristow K, Colgan JP, Habermann TM, Witzig TE, Inwards DJ et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma. Hematologica 2012; 97: 262-269.
2. Koh YW, Kang HJ, Park C, Yoon DH, Kim S, Suh C et al. The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages. Oncologist 2012; 17: 871-880.
3. Cox DR, Habermann TM, Payne BA, Klee GC, Pierre RV. Evaluation of the Coulter counter model S-Plus IV. Am J Clin Pathol 1985; 84: 297-306.
4. Hasenclever D, Diehl VA. A prognostic score for advanced Hodgkin disease. N Engl J Med 1998; 339: 1506-1514.
5. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25: 579-586.
6. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
7. Cox DR. Regression models and life-tables. J R Stat Soc Ser B 1972; 34: 187-202.
8. Sun D, Elson P, Liedtke M, Medeiros BC, Earl M, Alizadeh A et al. Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia. Am J Hematol 2012; 87: 957-960.
9. Behl D, Porrata LF, Markovic SN, Letendre L, Pruthi PK, Hook CC et al. Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia. Leukemia 2006; 20: 29-34.
10. Chae YS, Shin H, Sohn SK, Lee SJ, Moon JH, Kang BW et al. Absolute lymphocyte count at day21 predicts survival in patients with early-stage diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, Adriamycin, vincristine and prednisone. Leuk Lymph 2012; 53: 1757-1763.
11. Porrata LF, Ristow K, Habermann TM, Ozsan N, Dogan A, Macon W et al. Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma. Leuk Lymph 2012; 53: 2159-2165.
12. Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T et al. Tumor-associated macrophages and survival in classical Hodgkin's lymphoma. N Engl J Med 2010; 362: 875-885.
13. Ribatti D, Nico B, Crivellato E, Vacca A. Macrophages and tumor angiogenesis. Leukemia 2007; 21: 2085-2089.
14. Green CE, Liu T, Montel V, Hsiao G, Lester RD, Subramaniam S et al. Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis, and neovascularization. PLoS ONE 2009; 4: e6713.
15. Roca H, Varsos ZS, Sud S, Craig MJ, Ying C, Piena KJ. CCL2 and interleukin 6 promote survival of human CD11 b peripheral blood mononuclear cells and induce M2-type macrophages polarization. J Biol Chem 2009; 284: 34342-34354.
16. Dirkx AE, Oude Egbrink MG, Wagstaff J, Griffioen AW. Monocyte/macrophages infiltration in tumors modulators of angiogenesis. J Leukocyte Bio 2006; 80: 1183-1196.